메뉴 건너뛰기
Journal of Experimental Medicine
Volumn 214, Issue 2, 2017, Pages 269-283
Human immunity against EBV-lessons from the clinic
Author keywords

[No Author keywords available]
Indexed keywords

ADAPTIVE IMMUNITY; ALLOGENIC BONE MARROW TRANSPLANTATION; CD27 DEFICIENCY; CD70 DEFICIENCY; CELL THERAPY; CELLULAR IMMUNITY; CLINICAL OUTCOME; DISEASE ASSOCIATION; EPITHELIUM CELL; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE MUTATION; HEMOPHAGOCYTIC SYNDROME; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INTERLEUKIN 2 INDUCIBLE T CELL KINASE DEFICIENCY; LYMPHOPROLIFERATIVE DISEASE; MEMORY CELL; MONONUCLEOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION; X LINKED LYMPHOPROLIFERATIVE DISEASE; XMEN DISEASE; ADOPTIVE IMMUNOTHERAPY; ANIMAL; CD4+ T LYMPHOCYTE; GENETICS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGY; NATURAL KILLER CELL; PHYSIOLOGY; SIGNAL TRANSDUCTION;
EID: 85012292927     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20161846     Document Type: Review
Times cited : (139)
References (129)
  • 2
    • 84929840480 scopus 로고    scopus 로고
    • X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome
    • Aguilar, C., and S. Latour. 2015. X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome. J. Clin. Immunol. 35:331-338. http://dx.doi.org/10.1007/s10875-015-0141-9
    • (2015) J. Clin. Immunol , vol.35 , pp. 331-338
    • Aguilar, C.1    Latour, S.2
  • 4
    • 0141449970 scopus 로고    scopus 로고
    • Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection
    • Amyes, E., C. Hatton, D. Montamat-Sicotte, N. Gudgeon, A.B. Rickinson, A.J. McMichael, and M.F. Callan. 2003. Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection. J. Exp. Med. 198:903-911. http://dx.doi.org/10.1084/jem.20022058
    • (2003) J. Exp. Med , vol.198 , pp. 903-911
    • Amyes, E.1    Hatton, C.2    Montamat-Sicotte, D.3    Gudgeon, N.4    Rickinson, A.B.5    McMichael, A.J.6    Callan, M.F.7
  • 6
    • 84872981290 scopus 로고    scopus 로고
    • Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students
    • Balfour, H.H. Jr., O.A. Odumade, D.O. Schmeling, B.D. Mullan, J.A. Ed, J.A. Knight, H.E. Vezina, W. Thomas, and K.A. Hogquist. 2013. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J. Infect. Dis. 207:80-88. http://dx.doi.org/10.1093/infdis/jis646
    • (2013) J. Infect. Dis , vol.207 , pp. 80-88
    • Balfour, H.H.1    Odumade, O.A.2    Schmeling, D.O.3    Mullan, B.D.4    Ed, J.A.5    Knight, J.A.6    Vezina, H.E.7    Thomas, W.8    Hogquist, K.A.9
  • 8
    • 84943358637 scopus 로고    scopus 로고
    • High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency
    • Bienemann, K., A. Borkhardt, W. Klapper, and I. Oschlies. 2015. High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency. Histopathology. 67:607-616. http://dx.doi.org/10.1111/his.12677
    • (2015) Histopathology , vol.67 , pp. 607-616
    • Bienemann, K.1    Borkhardt, A.2    Klapper, W.3    Oschlies, I.4
  • 9
    • 84977277258 scopus 로고    scopus 로고
    • T cells for viral infections after allogeneic hematopoietic stem cell transplant
    • Bollard, C.M., and H.E. Heslop. 2016. T cells for viral infections after allogeneic hematopoietic stem cell transplant. Blood. 127:3331-3340. http://dx.doi.org/10.1182/blood-2016-01-628982
    • (2016) Blood , vol.127 , pp. 3331-3340
    • Bollard, C.M.1    Heslop, H.E.2
  • 10
    • 84898647949 scopus 로고    scopus 로고
    • Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins
    • Bollard, C.M., S. Gottschalk, V. Torrano, O. Diouf, S. Ku, Y. Hazrat, G. Carrum, C. Ramos, L. Fayad, E.J. Shpall, et al. 2014. Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins. J. Clin. Oncol. 32:798-808. http://dx.doi.org/10.1200/JCO.2013.51.5304
    • (2014) J. Clin. Oncol , vol.32 , pp. 798-808
    • Bollard, C.M.1    Gottschalk, S.2    Torrano, V.3    Diouf, O.4    Ku, S.5    Hazrat, Y.6    Carrum, G.7    Ramos, C.8    Fayad, L.9    Shpall, E.J.10
  • 11
    • 78650984696 scopus 로고    scopus 로고
    • X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease
    • Booth, C., K.C. Gilmour, P. Veys, A.R. Gennery, M.A. Slatter, H. Chapel, P.T. Heath, C.G. Steward, O. Smith, A. O'Meara, et al. 2011. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood. 117:53-62. http://dx.doi.org/10.1182/blood-2010-06-284935
    • (2011) Blood , vol.117 , pp. 53-62
    • Booth, C.1    Gilmour, K.C.2    Veys, P.3    Gennery, A.R.4    Slatter, M.A.5    Chapel, H.6    Heath, P.T.7    Steward, C.G.8    Smith, O.9    O'Meara, A.10
  • 12
    • 18844364782 scopus 로고    scopus 로고
    • CD27 and CD70 in T cell and B cell activation
    • Borst, J., J. Hendriks, and Y. Xiao. 2005. CD27 and CD70 in T cell and B cell activation. Curr. Opin. Immunol. 17:275-281. http://dx.doi.org/10.1016/j.coi.2005.04.004
    • (2005) Curr. Opin. Immunol , vol.17 , pp. 275-281
    • Borst, J.1    Hendriks, J.2    Xiao, Y.3
  • 13
    • 0035817326 scopus 로고    scopus 로고
    • NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease
    • Bottino, C., M. Falco, S. Parolini, E. Marcenaro, R. Augugliaro, S. Sivori, E. Landi, R. Biassoni, L.D. Notarangelo, L. Moretta, and A. Moretta. 2001. NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 194:235-246. http://dx.doi.org/10.1084/jem.194.3.235
    • (2001) J. Exp. Med , vol.194 , pp. 235-246
    • Bottino, C.1    Falco, M.2    Parolini, S.3    Marcenaro, E.4    Augugliaro, R.5    Sivori, S.6    Landi, E.7    Biassoni, R.8    Notarangelo, L.D.9    Moretta, L.10    Moretta, A.11
  • 15
    • 84872943896 scopus 로고    scopus 로고
    • Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions
    • Brennan, P.J., M. Brigl, and M.B. Brenner. 2013. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat. Rev. Immunol. 13:101-117. http://dx.doi.org/10.1038/nri3369
    • (2013) Nat. Rev. Immunol , vol.13 , pp. 101-117
    • Brennan, P.J.1    Brigl, M.2    Brenner, M.B.3
  • 17
    • 84979645718 scopus 로고    scopus 로고
    • Course of IL-2-inducible T-cell kinase deficiency in a family: lymphomatoid granulomatosis, lymphoma and allogeneic bone marrow transplantation in one sibling; and death in the other
    • çagdas, D., B. Erman, D. Hanoglu, B. Tavil, B. Kuskonmaz, B. Aydin, C. Akyüz, D. Uçkan, ö. Sanal, and I. Tezcan. 2017. Course of IL-2-inducible T-cell kinase deficiency in a family: lymphomatoid granulomatosis, lymphoma and allogeneic bone marrow transplantation in one sibling; and death in the other. Bone Marrow Transplant. 52:126-129. http://dx.doi.org/10.1038/bmt.2016.185
    • (2017) Bone Marrow Transplant , vol.52 , pp. 126-129
    • Çagdas, D.1    Erman, B.2    Hanoglu, D.3    Tavil, B.4    Kuskonmaz, B.5    Aydin, B.6    Akyüz, C.7    Uçkan, D.8    Sanal, Ö.9    Tezcan, I.10
  • 20
    • 0034733682 scopus 로고    scopus 로고
    • A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling
    • Chan, F.K., H.J. Chun, L. Zheng, R.M. Siegel, K.L. Bui, and M.J. Lenardo. 2000. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science. 288:2351-2354. http://dx.doi.org/10.1126/science.288.5475.2351
    • (2000) Science , vol.288 , pp. 2351-2354
    • Chan, F.K.1    Chun, H.J.2    Zheng, L.3    Siegel, R.M.4    Bui, K.L.5    Lenardo, M.J.6
  • 22
    • 84989283935 scopus 로고    scopus 로고
    • NK cell influence on the outcome of primary Epstein-Barr virus infection
    • Chijioke, O., V. Landtwing, and C. Münz. 2016. NK cell influence on the outcome of primary Epstein-Barr virus infection. Front. Immunol. 7:323. http://dx.doi.org/10.3389/fimmu.2016.00323
    • (2016) Front. Immunol , vol.7 , pp. 323
    • Chijioke, O.1    Landtwing, V.2    Münz, C.3
  • 25
    • 17344372694 scopus 로고    scopus 로고
    • Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene
    • Coffey, A.J., R.A. Brooksbank, O. Brandau, T. Oohashi, G.R. Howell, J.M. Bye, A.P. Cahn, J. Durham, P. Heath, P. Wray, et al. 1998. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 20:129-135. http://dx.doi.org/10.1038/2424
    • (1998) Nat. Genet , vol.20 , pp. 129-135
    • Coffey, A.J.1    Brooksbank, R.A.2    Brandau, O.3    Oohashi, T.4    Howell, G.R.5    Bye, J.M.6    Cahn, A.P.7    Durham, J.8    Heath, P.9    Wray, P.10
  • 26
    • 85083544825 scopus 로고    scopus 로고
    • Epstein-barr virus vaccines
    • Cohen, J.I. 2015a. Epstein-barr virus vaccines. Clin. Transl. Immunology. 4:e32. http://dx.doi.org/10.1038/cti.2014.27
    • (2015) Clin. Transl. Immunology , vol.4
    • Cohen, J.I.1
  • 27
    • 84942909324 scopus 로고    scopus 로고
    • Primary immunodeficiencies associated with EBV disease
    • Cohen, J.I. 2015b. Primary immunodeficiencies associated with EBV disease. Curr. Top. Microbiol. Immunol. 390:241-265.
    • (2015) Curr. Top. Microbiol. Immunol , vol.390 , pp. 241-265
    • Cohen, J.I.1
  • 28
    • 34248659404 scopus 로고    scopus 로고
    • Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation
    • Comoli, P., S. Basso, M. Zecca, D. Pagliara, F. Baldanti, M.E. Bernardo, W. Barberi, A. Moretta, M. Labirio, M. Paulli, et al. 2007. Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation. Am. J. Transplant. 7:1648-1655. http://dx.doi.org/10.1111/j.1600-6143.2007.01823.x
    • (2007) Am. J. Transplant , vol.7 , pp. 1648-1655
    • Comoli, P.1    Basso, S.2    Zecca, M.3    Pagliara, D.4    Baldanti, F.5    Bernardo, M.E.6    Barberi, W.7    Moretta, A.8    Labirio, M.9    Paulli, M.10
  • 31
    • 84858683311 scopus 로고    scopus 로고
    • Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
    • Doubrovina, E., B. Oflaz-Sozmen, S.E. Prockop, N.A. Kernan, S. Abramson, J. Teruya-Feldstein, C. Hedvat, J.F. Chou, G. Heller, J.N. Barker, et al. 2012. Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation. Blood. 119:2644-2656. http://dx.doi.org/10.1182/blood-2011-08-371971
    • (2012) Blood , vol.119 , pp. 2644-2656
    • Doubrovina, E.1    Oflaz-Sozmen, B.2    Prockop, S.E.3    Kernan, N.A.4    Abramson, S.5    Teruya-Feldstein, J.6    Hedvat, C.7    Chou, J.F.8    Heller, G.9    Barker, J.N.10
  • 33
    • 78149356369 scopus 로고    scopus 로고
    • X-linked lymphoproliferative syndromes: brothers or distant cousins?
    • Filipovich, A.H., K. Zhang, A.L. Snow, and R.A. Marsh. 2010. X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood. 116:3398-3408. http://dx.doi.org/10.1182/blood-2010-03-275909
    • (2010) Blood , vol.116 , pp. 3398-3408
    • Filipovich, A.H.1    Zhang, K.2    Snow, A.L.3    Marsh, R.A.4
  • 34
    • 11844287671 scopus 로고    scopus 로고
    • Epstein-Barr virus (EBV) infection in epithelial cells in vivo: rare detection of EBV replication in tongue mucosa but not in salivary glands
    • Frangou, P., M. Buettner, and G. Niedobitek. 2005. Epstein-Barr virus (EBV) infection in epithelial cells in vivo: rare detection of EBV replication in tongue mucosa but not in salivary glands. J. Infect. Dis. 191:238-242. http://dx.doi.org/10.1086/426823
    • (2005) J. Infect. Dis , vol.191 , pp. 238-242
    • Frangou, P.1    Buettner, M.2    Niedobitek, G.3
  • 35
    • 34249909831 scopus 로고    scopus 로고
    • Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID)
    • Garibyan, L., A.A. Lobito, R.M. Siegel, M.E. Call, K.W. Wucherpfennig, and R.S. Geha. 2007. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID). J. Clin. Invest. 117:1550-1557. http://dx.doi.org/10.1172/JCI31023
    • (2007) J. Clin. Invest , vol.117 , pp. 1550-1557
    • Garibyan, L.1    Lobito, A.A.2    Siegel, R.M.3    Call, M.E.4    Wucherpfennig, K.W.5    Geha, R.S.6
  • 36
    • 84912042007 scopus 로고    scopus 로고
    • Interleukin-2-inducible T-cell kinase (ITK) deficiency-clinical and molecular aspects
    • Ghosh, S., K. Bienemann, K. Boztug, and A. Borkhardt. 2014. Interleukin-2-inducible T-cell kinase (ITK) deficiency-clinical and molecular aspects. J. Clin. Immunol. 34:892-899. http://dx.doi.org/10.1007/s10875-014-0110-8
    • (2014) J. Clin. Immunol , vol.34 , pp. 892-899
    • Ghosh, S.1    Bienemann, K.2    Boztug, K.3    Borkhardt, A.4
  • 37
    • 0034733164 scopus 로고    scopus 로고
    • Signal transduction
    • Golstein, P. 2000. Signal transduction. FasL binds preassembled Fas. Science. 288:2328-2329. http://dx.doi.org/10.1126/science.288.5475.2328
    • (2000) FasL binds preassembled Fas. Science , vol.288 , pp. 2328-2329
    • Golstein, P.1
  • 38
    • 84874906669 scopus 로고    scopus 로고
    • Introduction: Infections in solid organ transplantation
    • Green, M. 2013. Introduction: Infections in solid organ transplantation. Am. J. Transplant. 13:3-8. http://dx.doi.org/10.1111/ajt.12093
    • (2013) Am. J. Transplant , vol.13 , pp. 3-8
    • Green, M.1
  • 39
    • 12944328008 scopus 로고    scopus 로고
    • Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells
    • Gustafsson, A., V. Levitsky, J.Z. Zou, T. Frisan, T. Dalianis, P. Ljungman, O. Ringden, J. Winiarski, I. Ernberg, and M.G. Masucci. 2000. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood. 95:807-814.
    • (2000) Blood , vol.95 , pp. 807-814
    • Gustafsson, A.1    Levitsky, V.2    Zou, J.Z.3    Frisan, T.4    Dalianis, T.5    Ljungman, P.6    Ringden, O.7    Winiarski, J.8    Ernberg, I.9    Masucci, M.G.10
  • 41
    • 34548025068 scopus 로고    scopus 로고
    • Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
    • Haque, T., G.M. Wilkie, M.M. Jones, C.D. Higgins, G. Urquhart, P. Wingate, D. Burns, K. McAulay, M. Turner, C. Bellamy, et al. 2007. Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood. 110:1123-1131. http://dx.doi.org/10.1182/blood-2006-12-063008
    • (2007) Blood , vol.110 , pp. 1123-1131
    • Haque, T.1    Wilkie, G.M.2    Jones, M.M.3    Higgins, C.D.4    Urquhart, G.5    Wingate, P.6    Burns, D.7    McAulay, K.8    Turner, M.9    Bellamy, C.10
  • 42
    • 0036941104 scopus 로고    scopus 로고
    • Epstein-Barr virus replication in tongue epithelial cells
    • Herrmann, K., P. Frangou, J. Middeldorp, and G. Niedobitek. 2002. Epstein-Barr virus replication in tongue epithelial cells. J. Gen. Virol. 83:2995-2998. http://dx.doi.org/10.1099/0022-1317-83-12-2995
    • (2002) J. Gen. Virol , vol.83 , pp. 2995-2998
    • Herrmann, K.1    Frangou, P.2    Middeldorp, J.3    Niedobitek, G.4
  • 43
    • 77950394280 scopus 로고    scopus 로고
    • How I treat EBV lymphoproliferation
    • Heslop, H.E. 2009. How I treat EBV lymphoproliferation. Blood. 114:4002-4008. http://dx.doi.org/10.1182/blood-2009-07-143545
    • (2009) Blood , vol.114 , pp. 4002-4008
    • Heslop, H.E.1
  • 44
    • 0029924619 scopus 로고    scopus 로고
    • Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of genemodified virus-specific T lymphocytes
    • Heslop, H.E., C.Y. Ng, C. Li, C.A. Smith, S.K. Loftin, R.A. Krance, M.K. Brenner, and C.M. Rooney. 1996. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of genemodified virus-specific T lymphocytes. Nat. Med. 2:551-555. http://dx.doi.org/10.1038/nm0596-551
    • (1996) Nat. Med , vol.2 , pp. 551-555
    • Heslop, H.E.1    Ng, C.Y.2    Li, C.3    Smith, C.A.4    Loftin, S.K.5    Krance, R.A.6    Brenner, M.K.7    Rooney, C.M.8
  • 45
    • 77649221824 scopus 로고    scopus 로고
    • Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
    • Heslop, H.E., K.S. Slobod, M.A. Pule, G.A. Hale, A. Rousseau, C.A. Smith, C.M. Bollard, H. Liu, M.F. Wu, R.J. Rochester, et al. 2010. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood. 115:925-935. http://dx.doi.org/10.1182/blood-2009-08-239186
    • (2010) Blood , vol.115 , pp. 925-935
    • Heslop, H.E.1    Slobod, K.S.2    Pule, M.A.3    Hale, G.A.4    Rousseau, A.5    Smith, C.A.6    Bollard, C.M.7    Liu, H.8    Wu, M.F.9    Rochester, R.J.10
  • 47
    • 34247872819 scopus 로고    scopus 로고
    • Cellular responses to viral infection in humans: lessons from Epstein-Barr virus
    • Hislop, A.D., G.S. Taylor, D. Sauce, and A.B. Rickinson. 2007. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu. Rev. Immunol. 25:587-617. http://dx.doi.org/10.1146/annurev.immunol.25.022106.141553
    • (2007) Annu. Rev. Immunol , vol.25 , pp. 587-617
    • Hislop, A.D.1    Taylor, G.S.2    Sauce, D.3    Rickinson, A.B.4
  • 49
    • 66449085077 scopus 로고    scopus 로고
    • Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation
    • Huck, K., O. Feyen, T. Niehues, F. Rüschendorf, N. Hübner, H.J. Laws, T. Telieps, S. Knapp, H.H. Wacker, A. Meindl, et al. 2009. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J. Clin. Invest. 119:1350-1358. http://dx.doi.org/10.1172/JCI37901
    • (2009) J. Clin. Invest , vol.119 , pp. 1350-1358
    • Huck, K.1    Feyen, O.2    Niehues, T.3    Rüschendorf, F.4    Hübner, N.5    Laws, H.J.6    Telieps, T.7    Knapp, S.8    Wacker, H.H.9    Meindl, A.10
  • 50
    • 85008226660 scopus 로고    scopus 로고
    • The long and complicated relationship between Epstein-Barr virus and epithelial cells
    • Hutt-Fletcher, L.M. 2017. The long and complicated relationship between Epstein-Barr virus and epithelial cells. J. Virol. 91:e01677-16. http://dx.doi.org/10.1128/JVI.01677-16
    • (2017) J. Virol , vol.91
    • Hutt-Fletcher, L.M.1
  • 51
    • 85008474195 scopus 로고    scopus 로고
    • Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection
    • Izawa, K., E. Martin, C. Soudais, J. Bruneau, D. Boutboul, R. Rodriguez, C. Lenoir, A.D. Hislop, C. Besson, F. Touzot, et al. 2017. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection. J. Exp. Med. 214:73-89. http://dx.doi.org/10.1084/jem.20160784
    • (2017) J. Exp. Med , vol.214 , pp. 73-89
    • Izawa, K.1    Martin, E.2    Soudais, C.3    Bruneau, J.4    Boutboul, D.5    Rodriguez, R.6    Lenoir, C.7    Hislop, A.D.8    Besson, C.9    Touzot, F.10
  • 52
    • 0033849422 scopus 로고    scopus 로고
    • Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10
    • Jung, J., J. Choe, L. Li, and Y.S. Choi. 2000. Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10. Eur. J. Immunol. 30:2437-2443. http://dx.doi.org/10.1002/1521-4141(2000)30:8<2437::AID-IMMU2437>3.0.CO;2-M
    • (2000) Eur. J. Immunol , vol.30 , pp. 2437-2443
    • Jung, J.1    Choe, J.2    Li, L.3    Choi, Y.S.4
  • 53
    • 13044295992 scopus 로고    scopus 로고
    • Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
    • Khanna, R., S. Bell, M. Sherritt, A. Galbraith, S.R. Burrows, L. Rafter, B. Clarke, R. Slaughter, M.C. Falk, J. Douglass, et al. 1999. Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease. Proc. Natl. Acad. Sci. USA. 96:10391-10396. http://dx.doi.org/10.1073/pnas.96.18.10391
    • (1999) Proc. Natl. Acad. Sci. USA , vol.96 , pp. 10391-10396
    • Khanna, R.1    Bell, S.2    Sherritt, M.3    Galbraith, A.4    Burrows, S.R.5    Rafter, L.6    Clarke, B.7    Slaughter, R.8    Falk, M.C.9    Douglass, J.10
  • 54
    • 0034651548 scopus 로고    scopus 로고
    • CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation
    • Kuehnle, I., M.H. Huls, Z. Liu, M. Semmelmann, R.A. Krance, M.K. Brenner, C.M. Rooney, and H.E. Heslop. 2000. CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood. 95:1502-1505.
    • (2000) Blood , vol.95 , pp. 1502-1505
    • Kuehnle, I.1    Huls, M.H.2    Liu, Z.3    Semmelmann, M.4    Krance, R.A.5    Brenner, M.K.6    Rooney, C.M.7    Heslop, H.E.8
  • 55
    • 0142197627 scopus 로고    scopus 로고
    • B cells under influence: transformation of B cells by Epstein-Barr virus
    • Küppers, R. 2003. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat. Rev. Immunol. 3:801-812. http://dx.doi.org/10.1038/nri1201
    • (2003) Nat. Rev. Immunol , vol.3 , pp. 801-812
    • Küppers, R.1
  • 56
    • 33645745240 scopus 로고    scopus 로고
    • Spectrum of Epstein-Barr virus-associated diseases
    • Kutok, J.L., and F. Wang. 2006. Spectrum of Epstein-Barr virus-associated diseases. Annu. Rev. Pathol. 1:375-404. http://dx.doi.org/10.1146/annurev.pathol.1.110304.100209
    • (2006) Annu. Rev. Pathol , vol.1 , pp. 375-404
    • Kutok, J.L.1    Wang, F.2
  • 57
    • 84971325230 scopus 로고    scopus 로고
    • Stepwise phosphorylation of p65 promotes NF-κB activation and NK cell responses during target cell recognition
    • Kwon, H.J., G.E. Choi, S. Ryu, S.J. Kwon, S.C. Kim, C. Booth, K.E. Nichols, and H.S. Kim. 2016. Stepwise phosphorylation of p65 promotes NF-κB activation and NK cell responses during target cell recognition. Nat. Commun. 7:11686. http://dx.doi.org/10.1038/ncomms11686
    • (2016) Nat. Commun , vol.7 , pp. 11686
    • Kwon, H.J.1    Choi, G.E.2    Ryu, S.3    Kwon, S.J.4    Kim, S.C.5    Booth, C.6    Nichols, K.E.7    Kim, H.S.8
  • 58
    • 84961879643 scopus 로고    scopus 로고
    • NKG2D receptor and its ligands in host defense
    • Lanier, L.L. 2015. NKG2D receptor and its ligands in host defense. Cancer Immunol. Res. 3:575-582. http://dx.doi.org/10.1158/2326-6066.CIR-15-0098
    • (2015) Cancer Immunol. Res , vol.3 , pp. 575-582
    • Lanier, L.L.1
  • 59
    • 0034892688 scopus 로고    scopus 로고
    • Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4+ T-helper 1 responses
    • Leen, A., P. Meij, I. Redchenko, J. Middeldorp, E. Bloemena, A. Rickinson, and N. Blake. 2001. Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4+ T-helper 1 responses. J. Virol. 75:8649-8659. http://dx.doi.org/10.1128/JVI.75.18.8649-8659.2001
    • (2001) J. Virol , vol.75 , pp. 8649-8659
    • Leen, A.1    Meij, P.2    Redchenko, I.3    Middeldorp, J.4    Bloemena, E.5    Rickinson, A.6    Blake, N.7
  • 60
    • 0032392095 scopus 로고    scopus 로고
    • Control of lymphocyte function through CD27-CD70 interactions
    • Lens, S.M., K. Tesselaar, M.H. van Oers, and R.A. van Lier. 1998. Control of lymphocyte function through CD27-CD70 interactions. Semin. Immunol. 10:491-499. http://dx.doi.org/10.1006/smim.1998.0154
    • (1998) Semin. Immunol , vol.10 , pp. 491-499
    • Lens, S.M.1    Tesselaar, K.2    van Oers, M.H.3    van Lier, R.A.4
  • 62
    • 84860772152 scopus 로고    scopus 로고
    • Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBVassociated lymphoproliferative diseases
    • Linka, R.M., S.L. Risse, K. Bienemann, M. Werner, Y. Linka, F. Krux, C. Synaeve, R. Deenen, S. Ginzel, R. Dvorsky, et al. 2012. Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBVassociated lymphoproliferative diseases. Leukemia. 26:963-971. http://dx.doi.org/10.1038/leu.2011.371
    • (2012) Leukemia , vol.26 , pp. 963-971
    • Linka, R.M.1    Risse, S.L.2    Bienemann, K.3    Werner, M.4    Linka, Y.5    Krux, F.6    Synaeve, C.7    Deenen, R.8    Ginzel, S.9    Dvorsky, R.10
  • 63
    • 20144389912 scopus 로고    scopus 로고
    • CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines
    • Long, H.M., T.A. Haigh, N.H. Gudgeon, A.M. Leen, C.W. Tsang, J. Brooks, E. Landais, E. Houssaint, S.P. Lee, A.B. Rickinson, and G.S. Taylor. 2005. CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines. J. Virol. 79:4896-4907. http://dx.doi.org/10.1128/JVI.79.8.4896-4907.2005
    • (2005) J. Virol , vol.79 , pp. 4896-4907
    • Long, H.M.1    Haigh, T.A.2    Gudgeon, N.H.3    Leen, A.M.4    Tsang, C.W.5    Brooks, J.6    Landais, E.7    Houssaint, E.8    Lee, S.P.9    Rickinson, A.B.10    Taylor, G.S.11
  • 64
    • 84879559682 scopus 로고    scopus 로고
    • MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response
    • Long, H.M., O.L. Chagoury, A.M. Leese, G.B. Ryan, E. James, L.T. Morton, R.J. Abbott, S. Sabbah, W. Kwok, and A.B. Rickinson. 2013. MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response. J. Exp. Med. 210:933-949. http://dx.doi.org/10.1084/jem.20121437
    • (2013) J. Exp. Med , vol.210 , pp. 933-949
    • Long, H.M.1    Chagoury, O.L.2    Leese, A.M.3    Ryan, G.B.4    James, E.5    Morton, L.T.6    Abbott, R.J.7    Sabbah, S.8    Kwok, W.9    Rickinson, A.B.10
  • 65
    • 0032525146 scopus 로고    scopus 로고
    • Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation
    • Lucas, K.G., R.L. Burton, S.E. Zimmerman, J. Wang, K.G. Cornetta, K.A. Robertson, C.H. Lee, and D.J. Emanuel. 1998. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood. 91:3654-3661.
    • (1998) Blood , vol.91 , pp. 3654-3661
    • Lucas, K.G.1    Burton, R.L.2    Zimmerman, S.E.3    Wang, J.4    Cornetta, K.G.5    Robertson, K.A.6    Lee, C.H.7    Emanuel, D.J.8
  • 67
    • 77956508441 scopus 로고    scopus 로고
    • XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease
    • Marsh, R.A., L. Madden, B.J. Kitchen, R. Mody, B. McClimon, M.B. Jordan, J.J. Bleesing, K. Zhang, and A.H. Filipovich. 2010. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood. 116:1079-1082. http://dx.doi.org/10.1182/blood-2010-01-256099
    • (2010) Blood , vol.116 , pp. 1079-1082
    • Marsh, R.A.1    Madden, L.2    Kitchen, B.J.3    Mody, R.4    McClimon, B.5    Jordan, M.B.6    Bleesing, J.J.7    Zhang, K.8    Filipovich, A.H.9
  • 68
    • 84855964475 scopus 로고    scopus 로고
    • The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection
    • Mautner, J., and G.W. Bornkamm. 2012. The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection. Eur. J. Cell Biol. 91:31-35. http://dx.doi.org/10.1016/j.ejcb.2011.01.007
    • (2012) Eur. J. Cell Biol , vol.91 , pp. 31-35
    • Mautner, J.1    Bornkamm, G.W.2
  • 69
    • 11244283829 scopus 로고    scopus 로고
    • Cellular immunotherapy for viral infection after HSC transplantation
    • Moss, P., and A. Rickinson. 2005. Cellular immunotherapy for viral infection after HSC transplantation. Nat. Rev. Immunol. 5:9-20. http://dx.doi.org/10.1038/nri1526
    • (2005) Nat. Rev. Immunol , vol.5 , pp. 9-20
    • Moss, P.1    Rickinson, A.2
  • 71
    • 0033729573 scopus 로고    scopus 로고
    • Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity
    • Nakajima, H., M. Cella, A. Bouchon, H.L. Grierson, J. Lewis, C.S. Duckett, J.I. Cohen, and M. Colonna. 2000. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur. J. Immunol. 30:3309-3318. http://dx.doi.org/10.1002/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3
    • (2000) Eur. J. Immunol , vol.30 , pp. 3309-3318
    • Nakajima, H.1    Cella, M.2    Bouchon, A.3    Grierson, H.L.4    Lewis, J.5    Duckett, C.S.6    Cohen, J.I.7    Colonna, M.8
  • 72
    • 0036363305 scopus 로고    scopus 로고
    • Clinicopathologic characteristics of post-transplant lymphoproliferative disorders
    • Nalesnik, M.A. 2002. Clinicopathologic characteristics of post-transplant lymphoproliferative disorders. Recent Results Cancer Res. 159:9-18. http://dx.doi.org/10.1007/978-3-642-56352-2 2
    • (2002) Recent Results Cancer Res , vol.159 , pp. 9-18
    • Nalesnik, M.A.1
  • 75
    • 80052463886 scopus 로고    scopus 로고
    • + polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins
    • + polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins. Immunology. 134:161-171. http://dx.doi.org/10.1111/j.1365-2567.2011.03476.x
    • (2011) Immunology , vol.134 , pp. 161-171
    • Ning, R.J.1    Xu, X.Q.2    Chan, K.H.3    Chiang, A.K.4
  • 77
    • 84883232593 scopus 로고    scopus 로고
    • Natural killer cell deficiency
    • Orange, J.S. 2013. Natural killer cell deficiency. J. Allergy Clin. Immunol. 132:515-525. http://dx.doi.org/10.1016/j.jaci.2013.07.020
    • (2013) J. Allergy Clin. Immunol , vol.132 , pp. 515-525
    • Orange, J.S.1
  • 78
    • 81055126777 scopus 로고    scopus 로고
    • Major histocompatibility complex class II expression deficiency caused by a RFX ANK founder mutation: a survey of 35 patients
    • Ouederni, M., Q.B. Vincent, P. Frange, F. Touzot, S. Scerra, M. Bejaoui, A. Bousfiha, Y. Levy, B. Lisowska-Grospierre, D. Canioni, et al. 2011. Major histocompatibility complex class II expression deficiency caused by a RFX ANK founder mutation: a survey of 35 patients. Blood. 118:5108-5118. http://dx.doi.org/10.1182/blood-2011-05-352716
    • (2011) Blood , vol.118 , pp. 5108-5118
    • Ouederni, M.1    Vincent, Q.B.2    Frange, P.3    Touzot, F.4    Scerra, S.5    Bejaoui, M.6    Bousfiha, A.7    Levy, Y.8    Lisowska-Grospierre, B.9    Canioni, D.10
  • 79
    • 79551644967 scopus 로고    scopus 로고
    • Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)
    • Pachlopnik Schmid, J., D. Canioni, D. Moshous, F. Touzot, N. Mahlaoui, F. Hauck, H. Kanegane, E. Lopez-Granados, E. Mejstrikova, I. Pellier, et al. 2011. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood. 117:1522-1529. http://dx.doi.org/10.1182/blood-2010-07-298372
    • (2011) Blood , vol.117 , pp. 1522-1529
    • Pachlopnik Schmid, J.1    Canioni, D.2    Moshous, D.3    Touzot, F.4    Mahlaoui, N.5    Hauck, F.6    Kanegane, H.7    Lopez-Granados, E.8    Mejstrikova, E.9    Pellier, I.10
  • 80
    • 84949096575 scopus 로고    scopus 로고
    • Primary immunodeficiencies and the control of Epstein-Barr virus infection
    • Palendira, U., and A.B. Rickinson. 2015. Primary immunodeficiencies and the control of Epstein-Barr virus infection. Ann. N. Y. Acad. Sci. 1356:22-44. http://dx.doi.org/10.1111/nyas.12937
    • (2015) Ann. N. Y. Acad. Sci , vol.1356 , pp. 22-44
    • Palendira, U.1    Rickinson, A.B.2
  • 81
    • 82455175808 scopus 로고    scopus 로고
    • Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP
    • Palendira, U., C. Low, A. Chan, A.D. Hislop, E. Ho, T.G. Phan, E. Deenick, M.C. Cook, D.S. Riminton, S. Choo, et al. 2011. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP. PLoS Biol. 9:e1001187. http://dx.doi.org/10.1371/journal.pbio.1001187
    • (2011) PLoS Biol , vol.9
    • Palendira, U.1    Low, C.2    Chan, A.3    Hislop, A.D.4    Ho, E.5    Phan, T.G.6    Deenick, E.7    Cook, M.C.8    Riminton, D.S.9    Choo, S.10
  • 83
    • 84943292383 scopus 로고    scopus 로고
    • Cytokine-mediated loss of blood dendritic cells during Epstein-Barr virus-associated acute infectious mononucleosis: Implication for immune dysregulation
    • Panikkar, A., C. Smith, A. Hislop, N. Tellam, V. Dasari, K.A. Hogquist, M. Wykes, D.J. Moss, A. Rickinson, H.H. Balfour Jr., and R. Khanna. 2015a. Cytokine-mediated loss of blood dendritic cells during Epstein-Barr virus-associated acute infectious mononucleosis: Implication for immune dysregulation. J. Infect. Dis. 212:1957-1961. http://dx.doi.org/10.1093/infdis/jiv340
    • (2015) J. Infect. Dis , vol.212 , pp. 1957-1961
    • Panikkar, A.1    Smith, C.2    Hislop, A.3    Tellam, N.4    Dasari, V.5    Hogquist, K.A.6    Wykes, M.7    Moss, D.J.8    Rickinson, A.9    Balfour, H.H.10    Khanna, R.11
  • 84
    • 84938907507 scopus 로고    scopus 로고
    • Impaired Epstein-Barr virus-specific neutralizing antibody response during acute infectious mononucleosis is coincident with global B-cell dysfunction
    • Panikkar, A., C. Smith, A. Hislop, N. Tellam, V. Dasari, K.A. Hogquist, M. Wykes, D.J. Moss, A. Rickinson, H.H. Balfour Jr., and R. Khanna. 2015b. Impaired Epstein-Barr virus-specific neutralizing antibody response during acute infectious mononucleosis is coincident with global B-cell dysfunction. J. Virol. 89:9137-9141. http://dx.doi.org/10.1128/JVI.01293-15
    • (2015) J. Virol , vol.89 , pp. 9137-9141
    • Panikkar, A.1    Smith, C.2    Hislop, A.3    Tellam, N.4    Dasari, V.5    Hogquist, K.A.6    Wykes, M.7    Moss, D.J.8    Rickinson, A.9    Balfour, H.H.10    Khanna, R.11
  • 86
    • 84881628097 scopus 로고    scopus 로고
    • Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases
    • Parvaneh, N., A.H. Filipovich, and A. Borkhardt. 2013. Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases. Br. J. Haematol. 162:573-586. http://dx.doi.org/10.1111/bjh.12422
    • (2013) Br. J. Haematol , vol.162 , pp. 573-586
    • Parvaneh, N.1    Filipovich, A.H.2    Borkhardt, A.3
  • 87
    • 15444374149 scopus 로고    scopus 로고
    • Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product
    • Pasquier, B., L. Yin, M.C. Fondanèche, F. Relouzat, C. Bloch-Queyrat, N. Lambert, A. Fischer, G. de Saint-Basile, and S. Latour. 2005. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 201:695-701. http://dx.doi.org/10.1084/jem.20042432
    • (2005) J. Exp. Med , vol.201 , pp. 695-701
    • Pasquier, B.1    Yin, L.2    Fondanèche, M.C.3    Relouzat, F.4    Bloch-Queyrat, C.5    Lambert, N.6    Fischer, A.7    de Saint-Basile, G.8    Latour, S.9
  • 89
    • 84900447559 scopus 로고    scopus 로고
    • Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection
    • Petrara, M.R., R. Freguja, K. Gianesin, M. Zanchetta, and A. De Rossi. 2013. Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection. Front. Microbiol. 4:311. http://dx.doi.org/10.3389/fmicb.2013.00311
    • (2013) Front. Microbiol , vol.4 , pp. 311
    • Petrara, M.R.1    Freguja, R.2    Gianesin, K.3    Zanchetta, M.4    De Rossi, A.5
  • 90
    • 84948581722 scopus 로고    scopus 로고
    • Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015
    • Picard, C., W. Al-Herz, A. Bousfiha, J.L. Casanova, T. Chatila, M.E. Conley, C. Cunningham-Rundles, A. Etzioni, S.M. Holland, C. Klein, et al. 2015. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015. J. Clin. Immunol. 35:696-726. http://dx.doi.org/10.1007/s10875-015-0201-1
    • (2015) J. Clin. Immunol , vol.35 , pp. 696-726
    • Picard, C.1    Al-Herz, W.2    Bousfiha, A.3    Casanova, J.L.4    Chatila, T.5    Conley, M.E.6    Cunningham-Rundles, C.7    Etzioni, A.8    Holland, S.M.9    Klein, C.10
  • 91
    • 0016772146 scopus 로고
    • Acquired agammaglobulinemia after a life-threatening illness with clinical and laboratory features of infectious mononucleosis in three related male children
    • Provisor, A.J., J.J. Iacuone, R.R. Chilcote, R.G. Neiburger, and F.G. Crussi. 1975. Acquired agammaglobulinemia after a life-threatening illness with clinical and laboratory features of infectious mononucleosis in three related male children. N. Engl. J. Med. 293:62-65. http://dx.doi.org/10.1056/NEJM197507102930202
    • (1975) N. Engl. J. Med , vol.293 , pp. 62-65
    • Provisor, A.J.1    Iacuone, J.J.2    Chilcote, R.R.3    Neiburger, R.G.4    Crussi, F.G.5
  • 92
    • 0016772968 scopus 로고
    • X-linked recessive progressive combined variable immunodeficiency (Duncan's disease)
    • Purtilo, D.T., J.P. Yang, C.K. Cassel, R. Harper, S.R. Stephenson, B.H. Landing, and G.F. Vawter. 1975. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet. 305:935-941. http://dx.doi.org/10.1016/S0140-6736(75)92004-8
    • (1975) Lancet , vol.305 , pp. 935-941
    • Purtilo, D.T.1    Yang, J.P.2    Cassel, C.K.3    Harper, R.4    Stephenson, S.R.5    Landing, B.H.6    Vawter, G.F.7
  • 93
    • 61849110214 scopus 로고    scopus 로고
    • Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk
    • Readinger, J.A., K.L. Mueller, A.M. Venegas, R. Horai, and P.L. Schwartzberg. 2009. Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk. Immunol. Rev. 228:93-114. http://dx.doi.org/10.1111/j.1600-065X.2008.00757.x
    • (2009) Immunol. Rev , vol.228 , pp. 93-114
    • Readinger, J.A.1    Mueller, K.L.2    Venegas, A.M.3    Horai, R.4    Schwartzberg, P.L.5
  • 94
    • 84897438282 scopus 로고    scopus 로고
    • Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory
    • Rickinson, A.B., H.M. Long, U. Palendira, C. Münz, and A.D. Hislop. 2014. Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory. Trends Immunol. 35:159-169. http://dx.doi.org/10.1016/j.it.2014.01.003
    • (2014) Trends Immunol , vol.35 , pp. 159-169
    • Rickinson, A.B.1    Long, H.M.2    Palendira, U.3    Münz, C.4    Hislop, A.D.5
  • 96
    • 0028816546 scopus 로고
    • Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
    • Rooney, C.M., C.A. Smith, C.Y. Ng, S. Loftin, C. Li, R.A. Krance, M.K. Brenner, and H.E. Heslop. 1995. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet. 345:9-13. http://dx.doi.org/10.1016/S0140-6736(95)91150-2
    • (1995) Lancet , vol.345 , pp. 9-13
    • Rooney, C.M.1    Smith, C.A.2    Ng, C.Y.3    Loftin, S.4    Li, C.5    Krance, R.A.6    Brenner, M.K.7    Heslop, H.E.8
  • 98
    • 76549087625 scopus 로고    scopus 로고
    • + T cell immunity
    • + T cell immunity. Microbes Infect. 12:173-181. http://dx.doi.org/10.1016/j.micinf.2009.12.001
    • (2010) Microbes Infect , vol.12 , pp. 173-181
    • Rowe, M.1    Zuo, J.2
  • 99
    • 84874537855 scopus 로고    scopus 로고
    • Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27
    • Salzer, E., S. Daschkey, S. Choo, M. Gombert, E. Santos-Valente, S. Ginzel, M. Schwendinger, O.A. Haas, G. Fritsch, W.F. Pickl, et al. 2013. Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27. Haematologica. 98:473-478. http://dx.doi.org/10.3324/haematol.2012.068791
    • (2013) Haematologica , vol.98 , pp. 473-478
    • Salzer, E.1    Daschkey, S.2    Choo, S.3    Gombert, M.4    Santos-Valente, E.5    Ginzel, S.6    Schwendinger, M.7    Haas, O.A.8    Fritsch, G.9    Pickl, W.F.10
  • 101
    • 20044361817 scopus 로고    scopus 로고
    • Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease
    • Savoldo, B., C.M. Rooney, R.E. Quiros-Tejeira, Y. Caldwell, H.J. Wagner, T. Lee, M.J. Finegold, G. Dotti, H.E. Heslop, and J.A. Goss. 2005. Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease. Am. J. Transplant. 5:566-572. http://dx.doi.org/10.1111/j.1600-6143.2004.00693.x
    • (2005) Am. J. Transplant , vol.5 , pp. 566-572
    • Savoldo, B.1    Rooney, C.M.2    Quiros-Tejeira, R.E.3    Caldwell, Y.4    Wagner, H.J.5    Lee, T.6    Finegold, M.J.7    Dotti, G.8    Heslop, H.E.9    Goss, J.A.10
  • 102
    • 0032190081 scopus 로고    scopus 로고
    • The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
    • Sayos, J., C. Wu, M. Morra, N. Wang, X. Zhang, D. Allen, S. van Schaik, L. Notarangelo, R. Geha, M.G. Roncarolo, et al. 1998. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 395:462-469. http://dx.doi.org/10.1038/26683
    • (1998) Nature , vol.395 , pp. 462-469
    • Sayos, J.1    Wu, C.2    Morra, M.3    Wang, N.4    Zhang, X.5    Allen, D.6    van Schaik, S.7    Notarangelo, L.8    Geha, R.9    Roncarolo, M.G.10
  • 103
    • 84989318857 scopus 로고    scopus 로고
    • Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans
    • Schipp, C., S. Nabhani, K. Bienemann, N. Simanovsky, S. Kfir-Erenfeld, N. Assayag-Asherie, P.T. Oommen, S. Revel-Vilk, A. Hönscheid, M. Gombert, et al. 2016. Specific antibody deficiency and autoinflammatory disease extend the clinical and immunological spectrum of heterozygous NFKB1 loss-of-function mutations in humans. Haematologica. 101:e392-e396. http://dx.doi.org/10.3324/haematol.2016.145136
    • (2016) Haematologica , vol.101 , pp. e392-e396
    • Schipp, C.1    Nabhani, S.2    Bienemann, K.3    Simanovsky, N.4    Kfir-Erenfeld, S.5    Assayag-Asherie, N.6    Oommen, P.T.7    Revel-Vilk, S.8    Hönscheid, A.9    Gombert, M.10
  • 104
    • 84904872011 scopus 로고    scopus 로고
    • Identification of ITK deficiency as a novel genetic cause of idiopathic CD4+ T-cell lymphopenia
    • Serwas, N.K., D. Cagdas, S.A. Ban, K. Bienemann, E. Salzer, I. Tezcan, A. Borkhardt, O. Sanal, and K. Boztug. 2014. Identification of ITK deficiency as a novel genetic cause of idiopathic CD4+ T-cell lymphopenia. Blood. 124:655-657. http://dx.doi.org/10.1182/blood-2014-03-564930
    • (2014) Blood , vol.124 , pp. 655-657
    • Serwas, N.K.1    Cagdas, D.2    Ban, S.A.3    Bienemann, K.4    Salzer, E.5    Tezcan, I.6    Borkhardt, A.7    Sanal, O.8    Boztug, K.9
  • 105
    • 79958022405 scopus 로고    scopus 로고
    • Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cellmediated transfer infection
    • Shannon-Lowe, C., and M. Rowe. 2011. Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cellmediated transfer infection. PLoS Pathog. 7:e1001338. http://dx.doi.org/10.1371/journal.ppat.1001338
    • (2011) PLoS Pathog , vol.7
    • Shannon-Lowe, C.1    Rowe, M.2
  • 106
    • 0037910274 scopus 로고    scopus 로고
    • Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy
    • Sherritt, M.A., M. Bharadwaj, J.M. Burrows, L.E. Morrison, S.L. Elliott, J.E. Davis, L.M. Kear, R.E. Slaughter, S.C. Bell, A.J. Galbraith, et al. 2003. Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy. Transplantation. 75:1556-1560. http://dx.doi.org/10.1097/01.TP.0000058745.02123.6F
    • (2003) Transplantation , vol.75 , pp. 1556-1560
    • Sherritt, M.A.1    Bharadwaj, M.2    Burrows, J.M.3    Morrison, L.E.4    Elliott, S.L.5    Davis, J.E.6    Kear, L.M.7    Slaughter, R.E.8    Bell, S.C.9    Galbraith, A.J.10
  • 107
    • 0034733584 scopus 로고    scopus 로고
    • Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations
    • Siegel, R.M., J.K. Frederiksen, D.A. Zacharias, F.K. Chan, M. Johnson, D. Lynch, R.Y. Tsien, and M.J. Lenardo. 2000. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science. 288:2354-2357. http://dx.doi.org/10.1126/science.288.5475.2354
    • (2000) Science , vol.288 , pp. 2354-2357
    • Siegel, R.M.1    Frederiksen, J.K.2    Zacharias, D.A.3    Chan, F.K.4    Johnson, M.5    Lynch, D.6    Tsien, R.Y.7    Lenardo, M.J.8
  • 108
    • 82555165254 scopus 로고    scopus 로고
    • Hematopoietic stem cell transplantation for primary immunodeficiency diseases
    • Slatter, M.A., and A.J. Cant. 2011. Hematopoietic stem cell transplantation for primary immunodeficiency diseases. Ann. N. Y. Acad. Sci. 1238:122-131. http://dx.doi.org/10.1111/j.1749-6632.2011.06243.x
    • (2011) Ann. N. Y. Acad. Sci , vol.1238 , pp. 122-131
    • Slatter, M.A.1    Cant, A.J.2
  • 110
    • 39149121505 scopus 로고    scopus 로고
    • Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults
    • Sokal, E.M., K. Hoppenbrouwers, C. Vandermeulen, M. Moutschen, P. Léonard, A. Moreels, M. Haumont, A. Bollen, F. Smets, and M. Denis. 2007. Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults. J. Infect. Dis. 196:1749-1753. http://dx.doi.org/10.1086/523813
    • (2007) J. Infect. Dis , vol.196 , pp. 1749-1753
    • Sokal, E.M.1    Hoppenbrouwers, K.2    Vandermeulen, C.3    Moutschen, M.4    Léonard, P.5    Moreels, A.6    Haumont, M.7    Bollen, A.8    Smets, F.9    Denis, M.10
  • 113
    • 40349084108 scopus 로고    scopus 로고
    • Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-γ
    • Strowig, T., F. Brilot, F. Arrey, G. Bougras, D. Thomas, W.A. Muller, and C. Münz. 2008. Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-γ PLoS Pathog. 4:e27. http://dx.doi.org/10.1371/journal.ppat.0040027
    • (2008) PLoS Pathog , vol.4
    • Strowig, T.1    Brilot, F.2    Arrey, F.3    Bougras, G.4    Thomas, D.5    Muller, W.A.6    Münz, C.7
  • 114
    • 0019255923 scopus 로고
    • Deficient natural killer cell activity in x-linked lymphoproliferative syndrome
    • Sullivan, J.L., K.S. Byron, F.E. Brewster, and D.T. Purtilo. 1980. Deficient natural killer cell activity in x-linked lymphoproliferative syndrome. Science. 210:543-545. http://dx.doi.org/10.1126/science.6158759
    • (1980) Science , vol.210 , pp. 543-545
    • Sullivan, J.L.1    Byron, K.S.2    Brewster, F.E.3    Purtilo, D.T.4
  • 115
    • 0034331249 scopus 로고    scopus 로고
    • Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease
    • Sumegi, J., D. Huang, A. Lanyi, J.D. Davis, T.A. Seemayer, A. Maeda, G. Klein, M. Seri, H. Wakiguchi, D.T. Purtilo, and T.G. Gross. 2000. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood. 96:3118-3125.
    • (2000) Blood , vol.96 , pp. 3118-3125
    • Sumegi, J.1    Huang, D.2    Lanyi, A.3    Davis, J.D.4    Seemayer, T.A.5    Maeda, A.6    Klein, G.7    Seri, M.8    Wakiguchi, H.9    Purtilo, D.T.10    Gross, T.G.11
  • 116
    • 84930898417 scopus 로고    scopus 로고
    • XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP
    • Tangye, S.G. 2014. XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP. J. Clin. Immunol. 34:772-779. http://dx.doi.org/10.1007/s10875-014-0083-7
    • (2014) J. Clin. Immunol , vol.34 , pp. 772-779
    • Tangye, S.G.1
  • 117
    • 70249085594 scopus 로고    scopus 로고
    • Memory B cells: effectors of longlived immune responses
    • Tangye, S.G., and D.M. Tarlinton. 2009. Memory B cells: effectors of longlived immune responses. Eur. J. Immunol. 39:2065-2075. http://dx.doi.org/10.1002/eji.200939531
    • (2009) Eur. J. Immunol , vol.39 , pp. 2065-2075
    • Tangye, S.G.1    Tarlinton, D.M.2
  • 118
    • 0034664724 scopus 로고    scopus 로고
    • Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome
    • Tangye, S.G., J.H. Phillips, L.L. Lanier, and K.E. Nichols. 2000. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J. Immunol. 165:2932-2936. http://dx.doi.org/10.4049/jimmunol.165.6.2932
    • (2000) J. Immunol , vol.165 , pp. 2932-2936
    • Tangye, S.G.1    Phillips, J.H.2    Lanier, L.L.3    Nichols, K.E.4
  • 119
    • 84927652740 scopus 로고    scopus 로고
    • The immunology of Epstein-Barr virus-induced disease
    • Taylor, G.S., H.M. Long, J.M. Brooks, A.B. Rickinson, and A.D. Hislop. 2015. The immunology of Epstein-Barr virus-induced disease. Annu. Rev. Immunol. 33:787-821. http://dx.doi.org/10.1146/annurev-immunol-032414-112326
    • (2015) Annu. Rev. Immunol , vol.33 , pp. 787-821
    • Taylor, G.S.1    Long, H.M.2    Brooks, J.M.3    Rickinson, A.B.4    Hislop, A.D.5
  • 120
    • 0031573077 scopus 로고    scopus 로고
    • Characterization of murine CD70, the ligand of the TNF receptor family member CD27
    • Tesselaar, K., L.A. Gravestein, G.M. van Schijndel, J. Borst, and R.A. van Lier. 1997. Characterization of murine CD70, the ligand of the TNF receptor family member CD27. J. Immunol. 159:4959-4965.
    • (1997) J. Immunol , vol.159 , pp. 4959-4965
    • Tesselaar, K.1    Gravestein, L.A.2    van Schijndel, G.M.3    Borst, J.4    van Lier, R.A.5
  • 123
    • 0020181223 scopus 로고
    • Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts
    • Thorley-Lawson, D.A., R.T. Schooley, A.K. Bhan, and L.M. Nadler. 1982. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts. Cell. 30:415-425. http://dx.doi.org/10.1016/0092-8674(82)90239-2
    • (1982) Cell , vol.30 , pp. 415-425
    • Thorley-Lawson, D.A.1    Schooley, R.T.2    Bhan, A.K.3    Nadler, L.M.4
  • 124
    • 0037097731 scopus 로고    scopus 로고
    • Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation
    • van Esser, J.W., H.G. Niesters, B. van der Holt, E. Meijer, A.D. Osterhaus, J.W. Gratama, L.F. Verdonck, B. Löwenberg, and J.J. Cornelissen. 2002. Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood. 99:4364-4369. http://dx.doi.org/10.1182/blood.V99.12.4364
    • (2002) Blood , vol.99 , pp. 4364-4369
    • van Esser, J.W.1    Niesters, H.G.2    van der Holt, B.3    Meijer, E.4    Osterhaus, A.D.5    Gratama, J.W.6    Verdonck, L.F.7    Löwenberg, B.8    Cornelissen, J.J.9
  • 129
    • 4944266319 scopus 로고    scopus 로고
    • Epstein-Barr virus: 40 years on
    • Young, L.S., and A.B. Rickinson. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer. 4:757-768. http://dx.doi.org/10.1038/nrc1452
    • (2004) Nat. Rev. Cancer , vol.4 , pp. 757-768
    • Young, L.S.1    Rickinson, A.B.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.